You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
君实生物-B(01877.HK):暂停在新三板转让 相关事项正在有序推进中
格隆汇 02-12 18:16

格隆汇2月12日丨君实生物-B(01877.HK)发布公告,君实生物(833330)拟首次公开发行股票并上市,根据有关规定,经公司向全国中小企业股份转让系统有限公司申请,公司于2019年9月24日在全国中小企业股份转让系统指定信息披露平台发布了《关于申请股票首次公开发行并上市进展暨停牌公告》(公告编号:2019-123),公司股票自2019年9月25日起在全国中小企业股份转让系统暂停转让。

2020年1月6日,公司收到了上交所出具的上证科审(审核)[2020]7号《关于上海君实生物医药科技股份有限公司首次公开发行股票并在科创板上市申请文件的第二轮审核问询函》。目前,公司首次公开发行股票并在科创板上市申请的审核状态为“中止(财报更新)”。

目前,相关事项正在有序推进中,公司将根据相关事项进展情况严格按照法律法规的规定和要求,及时履行信息披露义务。公司H股在联交所的买卖将不受影响。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account